Clinical  	Clinical  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
of  	of  	 IN	I-NP
Avène  	Avène  	 NNP	I-NP
hydrotherapy  	hydrotherapy  	 VBD	O
measured  	measured  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
large  	large  	 JJ	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
more  	more  	 JJR	O
than  	than  	 IN	O
10,000  	10,000  	 CD	O
atopic  	atopic  	 NNS	B-NP
or  	or  	 CC	O
psoriatic  	psoriatic  	 FW	B-NP
patients  	patients  	 FW	I-NP
Atopic  	Atopic  	 FW	I-NP
dermatitis  	dermatitis  	 FW	I-NP
( 	( 	 -LRB-	O
AD 	AD 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
psoriasis  	psoriasis  	 NNS	B-NP
are  	are  	 VBP	O
chronic  	chronic  	 JJ	B-NP
skin  	skin  	 NN	I-NP
conditions 	conditions 	 NNS	I-NP
.  	.  	 .	O
Local  	Local  	 JJ	O
or  	or  	 CC	O
systemic  	systemic  	 JJ	B-NP
treatments  	treatments  	 NNS	I-NP
are  	are  	 VBP	O
effective 	effective 	 JJ	O
,  	,  	 ,	O
but  	but  	 CC	O
their  	their  	 PRP$	O
effects  	effects  	 NNS	O
are  	are  	 VBP	O
transient 	transient 	 VBN	O
.  	.  	 .	O
Hydrotherapy 	Hydrotherapy 	 NNP	B-NP
,  	,  	 ,	O
used  	used  	 VBN	O
alone  	alone  	 RB	O
or  	or  	 CC	O
in  	in  	 IN	O
combination  	combination  	 NN	O
with  	with  	 IN	O
other  	other  	 JJ	O
treatments 	treatments 	 NNS	O
,  	,  	 ,	O
could  	could  	 MD	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
as  	as  	 IN	O
one  	one  	 CD	O
form  	form  	 NN	O
of  	of  	 IN	O
care  	care  	 NN	O
in  	in  	 IN	O
providing  	providing  	 VBG	O
effective  	effective  	 JJ	O
management  	management  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
dermatoses 	dermatoses 	 NN	B-NP
.  	.  	 .	O
The  	The  	 DT	O
objective  	objective  	 NN	B-NP
of  	of  	 IN	O
this  	this  	 DT	O
observational  	observational  	 JJ	B-NP
study  	study  	 NN	I-NP
was  	was  	 VBD	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
benefit  	benefit  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
3-week  	3-week  	 JJ	O
treatment  	treatment  	 NN	O
at  	at  	 IN	O
Avène  	Avène  	 NNP	O
Hydrotherapy  	Hydrotherapy  	 NNP	O
Centre  	Centre  	 NNP	O
in  	in  	 IN	O
a  	a  	 DT	O
very  	very  	 RB	O
large  	large  	 JJ	O
cohort  	cohort  	 NN	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
atopic  	atopic  	 JJ	B-NP
dermatitis  	dermatitis  	 NN	I-NP
and  	and  	 CC	O
psoriasis  	psoriasis  	 NNS	B-NP
and  	and  	 CC	O
to  	to  	 TO	O
assess  	assess  	 VB	O
the  	the  	 DT	O
treatment  	treatment  	 NN	B-NP
benefits  	benefits  	 NNS	I-NP
on  	on  	 IN	O
patients  	patients  	 NNS	O
undergoing  	undergoing  	 VBG	B-NP
hydrotherapy  	hydrotherapy  	 NN	I-NP
for  	for  	 IN	O
two  	two  	 CD	O
consecutive  	consecutive  	 JJ	O
years 	years 	 NNS	O
.  	.  	 .	O
This  	This  	 DT	O
8-year  	8-year  	 JJ	O
observational  	observational  	 JJ	B-NP
study  	study  	 NN	I-NP
analysed  	analysed  	 VBD	O
14,328  	14,328  	 CD	O
records  	records  	 NNS	O
of  	of  	 IN	O
patients  	patients  	 NNS	O
having  	having  	 VBG	O
a  	a  	 DT	O
dermatological  	dermatological  	 JJ	B-NP
disease  	disease  	 NN	I-NP
and  	and  	 CC	O
who  	who  	 WP	O
came  	came  	 VBD	O
to  	to  	 TO	O
Avène  	Avène  	 NNP	O
Hydrotherapy  	Hydrotherapy  	 NNP	O
Centre  	Centre  	 NNP	O
for  	for  	 IN	O
a  	a  	 DT	O
3-week  	3-week  	 JJ	O
treatment  	treatment  	 NN	O
between  	between  	 IN	O
2001  	2001  	 CD	O
and  	and  	 CC	O
2009 	2009 	 CD	O
.  	.  	 .	O
Among  	Among  	 IN	O
them 	them 	 PRP	O
,  	,  	 ,	O
patients  	patients  	 NNS	O
were  	were  	 VBD	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
atopic  	atopic  	 JJ	B-NP
dermatitis  	dermatitis  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
5916 	5916 	 CD	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
psoriasis  	psoriasis  	 NNS	B-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
4887 	4887 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
On  	On  	 IN	O
admission  	admission  	 NN	B-NP
on  	on  	 IN	O
D0  	D0  	 NNP	B-NP
( 	( 	 -LRB-	O
day  	day  	 NN	B-NP
0 	0 	 CD	I-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
at  	at  	 IN	O
the  	the  	 DT	O
end  	end  	 NN	O
of  	of  	 IN	O
cure  	cure  	 NN	O
on  	on  	 IN	O
D18  	D18  	 NNP	B-NP
( 	( 	 -LRB-	O
day  	day  	 NN	O
18 	18 	 CD	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
the  	the  	 DT	O
severity  	severity  	 NN	O
of  	of  	 IN	O
AD  	AD  	 NNP	O
and  	and  	 CC	O
psoriasis  	psoriasis  	 NNS	B-NP
were  	were  	 VBD	O
evaluated  	evaluated  	 VBN	O
by  	by  	 IN	O
SCORing  	SCORing  	 NNP	B-NP
Atopic  	Atopic  	 NNP	I-NP
Dermatitis  	Dermatitis  	 NNP	I-NP
( 	( 	 -LRB-	O
SCORAD 	SCORAD 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
Psoriasis  	Psoriasis  	 NNP	B-NP
Area  	Area  	 NNP	I-NP
and  	and  	 CC	I-NP
Severity  	Severity  	 NNP	I-NP
Index  	Index  	 NNP	I-NP
( 	( 	 -LRB-	O
PASI 	PASI 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
In  	In  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
assess  	assess  	 VB	O
the  	the  	 DT	O
cumulative  	cumulative  	 JJ	B-NP
effect  	effect  	 NN	I-NP
of  	of  	 IN	I-NP
the  	the  	 DT	I-NP
hydrotherapy  	hydrotherapy  	 JJ	I-NP
treatment 	treatment 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
evolution  	evolution  	 NN	B-NP
of  	of  	 IN	I-NP
SCORAD  	SCORAD  	 NNP	I-NP
or  	or  	 CC	O
PASI  	PASI  	 NNP	B-NP
of  	of  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
came  	came  	 VBD	O
2  	2  	 CD	O
years  	years  	 NNS	O
in  	in  	 IN	O
a  	a  	 DT	O
row  	row  	 NN	O
was  	was  	 VBD	O
also  	also  	 RB	O
calculated 	calculated 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
significant  	significant  	 JJ	O
improvement  	improvement  	 NN	O
in  	in  	 IN	O
SCORAD  	SCORAD  	 NNP	B-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
between  	between  	 IN	O
D0  	D0  	 NNP	O
and  	and  	 CC	O
D18  	D18  	 NNP	B-NP
( 	( 	 -LRB-	O
-41.6 	-41.6 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.0001 	0.0001 	 NNP	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
similarly 	similarly 	 RB	O
,  	,  	 ,	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
reduction  	reduction  	 NN	O
in  	in  	 IN	O
PASI  	PASI  	 NNP	B-NP
was  	was  	 VBD	O
noted  	noted  	 VBN	O
between  	between  	 IN	O
D0  	D0  	 NNP	O
and  	and  	 CC	O
D18  	D18  	 NNP	B-NP
( 	( 	 -LRB-	O
-54.4 	-54.4 	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.0001 	0.0001 	 NNP	O
)  	)  	 -RRB-	O
after  	after  	 IN	O
3-weeks  	3-weeks  	 CD	O
of  	of  	 IN	O
hydrotherapy 	hydrotherapy 	 NN	B-NP
.  	.  	 .	O
PASI  	PASI  	 NNP	B-NP
50  	50  	 CD	O
and  	and  	 CC	O
PASI  	PASI  	 NNP	B-NP
75  	75  	 CD	O
were  	were  	 VBD	O
64.3 	64.3 	 CD	O
%  	%  	 NN	O
and  	and  	 CC	O
19.5 	19.5 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
For  	For  	 IN	O
atopic  	atopic  	 JJ	B-NP
patients  	patients  	 NNS	I-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
1102 	1102 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
patients  	patients  	 NNS	O
suffering  	suffering  	 VBG	O
from  	from  	 IN	O
psoriasis  	psoriasis  	 NNS	B-NP
( 	( 	 -LRB-	O
n  	n  	 CD	O
=  	=  	 SYM	O
833 	833 	 CD	O
)  	)  	 -RRB-	O
who  	who  	 WP	O
came  	came  	 VBD	O
for  	for  	 IN	O
two  	two  	 CD	O
consecutive  	consecutive  	 JJ	O
years 	years 	 NNS	O
,  	,  	 ,	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
SCORAD  	SCORAD  	 NNP	B-NP
and  	and  	 CC	O
PASI  	PASI  	 NNP	B-NP
improvement  	improvement  	 NN	I-NP
was  	was  	 VBD	O
observed  	observed  	 VBN	O
on  	on  	 IN	O
D0  	D0  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
second  	second  	 JJ	O
year  	year  	 NN	O
when  	when  	 WRB	O
compared  	compared  	 VBN	O
with  	with  	 IN	O
D0  	D0  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
previous  	previous  	 JJ	O
year  	year  	 NN	O
( 	( 	 -LRB-	O
P  	P  	 NNP	O
< 	< 	 SYM	O
0.0001 	0.0001 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
This  	This  	 DT	O
study  	study  	 NN	O
is  	is  	 VBZ	O
the  	the  	 DT	O
first  	first  	 JJ	O
observational  	observational  	 JJ	B-NP
study  	study  	 NN	I-NP
in  	in  	 IN	O
such  	such  	 PDT	O
a  	a  	 DT	O
large  	large  	 JJ	O
cohort  	cohort  	 NNS	B-NP
demonstrating  	demonstrating  	 VBG	O
the  	the  	 DT	O
benefit  	benefit  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
3-week  	3-week  	 JJ	O
treatment  	treatment  	 NN	O
at  	at  	 IN	O
the  	the  	 DT	O
Avène  	Avène  	 NNP	B-NP
Hydrotherapy  	Hydrotherapy  	 NNP	I-NP
Centre  	Centre  	 NNP	I-NP
for  	for  	 IN	I-NP
atopic  	atopic  	 NN	I-NP
and  	and  	 CC	O
psoriatic  	psoriatic  	 JJ	B-NP
patients 	patients 	 NNS	I-NP
.  	.  	 .	O
